Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
4.950
-0.120 (-2.37%)
At close: Dec 20, 2024, 4:00 PM
4.990
+0.040 (0.81%)
After-hours: Dec 20, 2024, 5:47 PM EST
Sagimet Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -37.52 | -27.88 | -30.5 | -24.44 | -11.37 | -14.26 |
Depreciation & Amortization | - | - | - | - | - | 0 |
Other Amortization | - | - | - | - | - | 0.01 |
Loss (Gain) From Sale of Assets | - | - | - | - | -0.02 | - |
Loss (Gain) From Sale of Investments | -1.2 | -0.04 | -0.21 | - | - | - |
Stock-Based Compensation | 5.07 | 4.99 | 1.88 | 1.9 | 0.78 | 2.99 |
Other Operating Activities | 0.14 | 0.14 | 0.13 | 0.88 | 0.12 | 0.07 |
Change in Accounts Payable | -1.03 | 0.12 | 2.92 | 0.56 | -0.36 | 1.28 |
Change in Other Net Operating Assets | -3.96 | -1.1 | 1.3 | -0.62 | 0.44 | -0.63 |
Operating Cash Flow | -38.49 | -23.77 | -24.49 | -21.71 | -10.42 | -10.55 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.02 | - |
Investment in Securities | -91.15 | 12.58 | -32.01 | - | - | - |
Other Investing Activities | - | - | - | - | - | -0.03 |
Investing Cash Flow | -91.15 | 12.58 | -32.01 | - | 0.02 | -0.03 |
Long-Term Debt Repaid | - | - | - | - | - | -3.36 |
Net Debt Issued (Repaid) | - | - | - | - | - | -3.36 |
Issuance of Common Stock | 109.38 | 89.69 | 0.01 | 0.19 | - | - |
Other Financing Activities | -4.56 | -3.52 | -0.09 | -1.25 | - | - |
Financing Cash Flow | 104.82 | 86.17 | -0.07 | 9.74 | 68.89 | 18.49 |
Net Cash Flow | -24.83 | 74.98 | -56.57 | -11.97 | 58.49 | 7.91 |
Free Cash Flow | -38.49 | -23.77 | -24.49 | -21.71 | -10.42 | -10.55 |
Free Cash Flow Margin | - | -1188.30% | - | - | - | - |
Free Cash Flow Per Share | -1.32 | -2.27 | -132.65 | -177.11 | -107.87 | - |
Cash Interest Paid | - | - | - | - | - | 0.14 |
Levered Free Cash Flow | -28.21 | -15.08 | -13.21 | -14.27 | -5.96 | - |
Unlevered Free Cash Flow | -28.21 | -15.08 | -13.21 | -14.27 | -5.96 | - |
Change in Net Working Capital | 4.7 | 0.86 | -4.32 | 1.35 | -0.39 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.